Tenax Therapeutics, Inc. (TENX)

NASDAQ: TENX · Real-Time Price · USD

13.84

-0.35 (-2.47%)

At close: Mar 13, 2026, 4:00 PM EDT

13.70

-0.14 (-1.01%)

After-hours: Mar 13, 2026, 7:04 PM EDT

Tenax Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	97.57	94.85	9.79	2.12	5.58
Cash & Short-Term Investments	97.57	94.85	9.79	2.12	5.58
Cash Growth	2.86%	868.66%	361.09%	-61.97%	-16.82%
Other Current Assets	6.66	1.84	1.89	1.08	0.11
Total Current Assets	104.23	96.69	11.68	3.21	5.69
Net Property, Plant & Equipment	-	-	-	0.19	0.29
Other Long-Term Assets	-	-	0	0.01	0.01
Total Assets	104.23	96.69	11.69	3.4	5.99
Accounts Payable	6.04	3.16	2.07	0.45	0.86
Accrued Expenses	1.12	1.54	1.01	0.78	0.7
Current Portion of Long-Term Debt	-	-	0.5	0.62	-
Total Current Liabilities	7.16	4.69	3.59	1.85	1.56
Long-Term Leases	-	-	-	0.06	0.18
Total Long-Term Liabilities	-	-	-	0.06	0.18
Total Liabilities	7.16	4.69	3.59	1.91	1.75
Common Stock	0	-	-	0	0
Additional Paid-in Capital	464.52	406.85	305.35	291.03	282.74
Retained Earnings	-367.45	-314.86	-297.25	-289.54	-278.49
Shareholders' Equity	97.07	91.99	8.1	1.49	4.24
Total Liabilities & Equity	104.23	96.69	11.69	3.4	5.99
Total Debt	0	0	0.5	0.69	0.18
Net Cash (Debt)	97.57	94.85	9.29	1.44	5.4
Net Cash Growth	2.86%	920.89%	547.37%	-73.42%	-16.51%
Net Cash Per Share	2.49	6.21	37.40	78.04	5.25
Book Value	97.07	91.99	8.1	1.49	4.24
Book Value Per Share	2.48	6.02	32.59	81.17	4.13
Tangible Book Value	97.07	91.99	8.1	1.49	4.24
Tangible Book Value Per Share	2.48	6.02	32.59	81.17	4.13

Updated Mar 10, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q